Perspective Therapeutics (CATX) Inventory (2011 - 2023)

Perspective Therapeutics has disclosed Inventory across 13 years of filings, most recently posting $1.0 million for Q3 2023.

• Inventory for Q3 2023 came in at $1.0 million, down 34.77% year-over-year; the trailing twelve-month figure through Sep 2023 was $1.0 million (down 34.77% YoY), and the FY2022 annual result was $1.4 million, changed N/A from the prior year.
• Inventory came in at $1.0 million for Q3 2023 at Perspective Therapeutics, down from $1.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.6 million in Q3 2022 to a low of $501000.0 in Q3 2019.
• The 5-year median for Inventory is $980000.0 (2021), against an average of $921842.1.
• Across the five-year window, Inventory jumped 65.37% in 2021 and slumped 34.77% in 2023, its largest moves.
• Perspective Therapeutics' Inventory stood at $545000.0 in 2019, then climbed by 22.02% to $665000.0 in 2020, then surged by 60.6% to $1.1 million in 2021, then jumped by 31.93% to $1.4 million in 2022, then declined by 28.11% to $1.0 million in 2023.
• The last three Inventory figures came in at $1.0 million (Q3 2023), $1.1 million (Q2 2023), and $1.4 million (Q1 2023), per Business Quant data.